Vazzano Joseph Walter 4

What Happened
Joseph Walter Vazzano, Chief Financial Officer of Abeona Therapeutics (ABEO), reported the sale of 18,666 shares on 2026-01-22. The sales generated proceeds of approximately $99,507. The filing lists the transaction as a sale (Code S) and footnote F1 states the sale was to cover tax obligations related to the vesting of restricted stock awards.

Key Details

• Transaction date: 2026-01-22.
• Shares sold: 18,666.
• Reported proceeds: ~$99,507.
• Price: weighted average $5.33; individual sale prices ranged from $5.33 to $5.38 (Footnote F2). The reporting person can provide a per-price breakdown on request.
• Reason noted: tax withholding for vested restricted stock (Footnote F1).
• Shares owned after the transaction: not specified in the provided Form 4.
• Timeliness: Report filed on 2026-01-22 (same day), not indicated as late.

Context
Sales to cover tax withholding for vesting awards are common and typically considered routine (they do not necessarily indicate a change in the insider’s view of the company). The filing does not indicate a 10b5-1 trading plan or other trading arrangement.